JPWO2022040246A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022040246A5 JPWO2022040246A5 JP2023512048A JP2023512048A JPWO2022040246A5 JP WO2022040246 A5 JPWO2022040246 A5 JP WO2022040246A5 JP 2023512048 A JP2023512048 A JP 2023512048A JP 2023512048 A JP2023512048 A JP 2023512048A JP WO2022040246 A5 JPWO2022040246 A5 JP WO2022040246A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- inhibitors
- modulator
- biomaterial
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063066806P | 2020-08-17 | 2020-08-17 | |
| US202063066807P | 2020-08-17 | 2020-08-17 | |
| US63/066,806 | 2020-08-17 | ||
| US63/066,807 | 2020-08-17 | ||
| PCT/US2021/046392 WO2022040246A1 (en) | 2020-08-17 | 2021-08-17 | Immune modulation of myeloid derived suppressive cell function for cancer treatment |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023538590A JP2023538590A (ja) | 2023-09-08 |
| JP2023538590A5 JP2023538590A5 (https=) | 2024-08-23 |
| JPWO2022040246A5 true JPWO2022040246A5 (https=) | 2024-08-23 |
Family
ID=80323241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512048A Pending JP2023538590A (ja) | 2020-08-17 | 2021-08-17 | がんの処置のための骨髄由来抑制細胞機能の免疫調節 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230398146A1 (https=) |
| EP (1) | EP4196122A4 (https=) |
| JP (1) | JP2023538590A (https=) |
| KR (1) | KR20230079036A (https=) |
| CN (1) | CN116322702A (https=) |
| AU (1) | AU2021329884A1 (https=) |
| CA (1) | CA3189611A1 (https=) |
| IL (1) | IL300479A (https=) |
| WO (1) | WO2022040246A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115054579B (zh) * | 2022-05-30 | 2023-06-30 | 浙江大学 | 一种活性氧响应性梯度递药的纳米粒子关节炎药物及其制备方法 |
| EP4648778A1 (en) * | 2023-01-09 | 2025-11-19 | National Health Research Institutes | Method for treating netosis-mediated diseases |
| US20250101101A1 (en) | 2023-09-01 | 2025-03-27 | iTeos Belgium SA | Anti-trem2 antibodies and methods of use |
| WO2025259942A1 (en) * | 2024-06-13 | 2025-12-18 | Roswell Park Cancer Institute Corporation | Targeting immunosuppressive tumor microenvironment by blocking nicotinamide phosphoribosyltransferase (nampt) in myeloid cells |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080038316A1 (en) * | 2004-10-01 | 2008-02-14 | Wong Vernon G | Conveniently implantable sustained release drug compositions |
| US20110305765A1 (en) * | 2008-11-21 | 2011-12-15 | Board Of Regents, The University Of Texas System | Preparation and methodology of silk fibroin nanoparticles |
| CN101612400A (zh) * | 2009-07-22 | 2009-12-30 | 陈志龙 | 血管紧张素ⅱ的1型受体拮抗剂在抗肿瘤中的应用 |
| EP2905029B1 (en) * | 2012-10-04 | 2018-11-21 | Shionogi&Co., Ltd. | Drug for inhibiting malignant tumor metastasis |
| US9463198B2 (en) * | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
| US20170360912A1 (en) * | 2014-12-17 | 2017-12-21 | Socovar, L.P. | Chitosan-based hydrogel and applications thereof. |
| WO2016141151A1 (en) * | 2015-03-03 | 2016-09-09 | University Of Miami | Nanoparticle conjugates and uses thereof |
| CA2990852A1 (en) * | 2015-06-26 | 2016-12-29 | Beth Israel Deaconess Medical Center, Inc. | Cancer therapy targeting tetraspanin 33 (tspan33) in myeloid derived suppressor cells |
| FI3922279T3 (fi) * | 2016-08-30 | 2025-02-04 | Dana Farber Cancer Inst Inc | Lääkkeenantokoostumuksia ja niiden käyttötapoja |
| JP7404230B2 (ja) * | 2017-09-18 | 2023-12-25 | トラスティーズ オブ ボストン ユニバーシティ | ネトーシスおよび好中球活性化を処置するための方法 |
| IL305483A (en) * | 2018-03-20 | 2023-10-01 | Dana Farber Cancer Inst Inc | Preparations and methods for the treatment of cancer |
| CN113766929A (zh) * | 2019-05-02 | 2021-12-07 | 斯蒂米特公司 | 癌症治疗 |
| CN114401991A (zh) * | 2019-06-04 | 2022-04-26 | 维西欧制药公司 | 用于调节髓系细胞炎性表型的抗siglec-9组合物和方法及其用途 |
| KR20230041032A (ko) * | 2020-07-17 | 2023-03-23 | 서지 테라퓨틱스, 인크. | 중합체 복합 제제를 포함하는 제제 및 조성물 |
-
2021
- 2021-08-17 AU AU2021329884A patent/AU2021329884A1/en active Pending
- 2021-08-17 CN CN202180068578.9A patent/CN116322702A/zh active Pending
- 2021-08-17 EP EP21859012.3A patent/EP4196122A4/en active Pending
- 2021-08-17 CA CA3189611A patent/CA3189611A1/en active Pending
- 2021-08-17 US US18/021,634 patent/US20230398146A1/en active Pending
- 2021-08-17 JP JP2023512048A patent/JP2023538590A/ja active Pending
- 2021-08-17 KR KR1020237009144A patent/KR20230079036A/ko active Pending
- 2021-08-17 WO PCT/US2021/046392 patent/WO2022040246A1/en not_active Ceased
- 2021-08-17 IL IL300479A patent/IL300479A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sachan et al. | Sodium alginate: the wonder polymer for controlled drug delivery | |
| US20240399022A1 (en) | Compositions and methods for macrophage conversion | |
| JP6306198B2 (ja) | 医療用導管用の生体内投与性マイクロ粒子 | |
| HU209243B (en) | Long acting coated compositions | |
| US20230398146A1 (en) | Immune modulation of myeloid derived suppressive cell function for cancer treatment | |
| US20110280952A1 (en) | Platelet Lysate and Bioadhesive Compositions Thereof for the Treatment of Mucositis | |
| PL187764B1 (pl) | Tabletki farmaceutyczne o kontrolowanym uwalnianiu zawierające nośnik oparty na sieciowanej amylozie i hydroksypropylometylocelulozie oraz zastosowanie hydroksypropylometylocelulozy | |
| JP2018528962A (ja) | 熱感受性ヒドロゲルコラゲナーゼ製剤 | |
| CN116133642A (zh) | 包含聚合物组合制备剂的制备剂和组合物 | |
| CN104010663A (zh) | 含酸式羧甲基纤维素和结晶纤维素的崩解性颗粒组合物及含该组合物的口腔内崩解片剂 | |
| CN103189078A (zh) | 含有透明质酸和l-精氨酸的抗粘连剂 | |
| CN106659823B (zh) | 热响应性防粘连用组合物及其用途 | |
| CN117357468B (zh) | 一种可长期储存的益生菌凝胶制剂及其使用方法和应用 | |
| HRP20170810T1 (hr) | Peptidi i spojevi koji se vežu za receptore trombopoietina | |
| Patlolla et al. | Evaluation of in vitro mucoadhesiveness and texture profile analysis of doxycycline in situ hydrogels | |
| JP2015013887A (ja) | アタシセプトなどのＴＡＣＩ−Ｉｇ融合タンパク質を用いた自己免疫疾患を治療するための投薬法 | |
| JPWO2022040246A5 (https=) | ||
| US20240082236A1 (en) | Cancer therapy | |
| JP2024532611A (ja) | 鼻腔薬物送達用の粘膜接着ポリマー | |
| CN101011393B (zh) | 厄贝沙坦胃内滞留型缓释药物组合物 | |
| JPWO2022016129A5 (https=) | ||
| JP7410876B2 (ja) | 血管閉塞のためにその場凝固複合コアセルベートを使用する装置及び方法 | |
| CZ291258B6 (cs) | Orální přípravek, obsahující v matrici bobtnatelné ve vodném prostředí alespoň jednu farmaceutickou účinnou látku | |
| Thakur et al. | Designing marine-derived carrageenan-based biomimetic functional materials via a green approach for sustainable development: cellular proliferation and mucosal tissue drug delivery applications | |
| TW202329924A (zh) | 含有麩醯胺酸的藥物組成物、製劑及其用途 |